Dr. Jason T. Kimata is an Associate Professor at the Baylor College of Medicine in Houston, TX, USA. He received his BA from Carleton College in 1988 and a Ph.D. from Washington University in 1993. He earned a Post-Doctoral Fellowship at the University of Washington in 1998. Currently, he is also a member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. His research interests include mechanisms of HIV persistence and disease, innate restriction and development of a macaque model of HIV-1 infection and disease, and engineering resistance to HIV-1. Future studies will evaluate whether GPI-anchored antibody derivatives can protect HIV-1-specific CD4+ T-cells from infection and if immunotherapy with these modified T-cells improves control of HIV-1 infection.
Dr. Jason T. Kimata is an Associate Professor at the Baylor College of Medicine in Houston, TX, USA. He received his BA from Carleton College in 1988 and a Ph.D. from Washington University in 1993. He earned a Post-Doctoral Fellowship at the University of Washington in 1998. Currently, he is also a member of the Dan L Duncan Comprehensive Cancer Center at Baylor College of Medicine. His research interests include mechanisms of HIV persistence and disease, innate restriction and development of a macaque model of HIV-1 infection and disease, and engineering resistance to HIV-1. Future studies will evaluate whether GPI-anchored antibody derivatives can protect HIV-1-specific CD4+ T-cells from infection and if immunotherapy with these modified T-cells improves control of HIV-1 infection.